Eagle Eye Equities
December 22, 2023
Index
Punter’s Call
Looking Trendy: Nifty
Looking Trendy: Sensex
Nifty Trader
Positional Weekly (Cash Only)
Positional 15 Days (Cash Only)
CTFT (Carry Today For Tomorrow) - Cash Only
Looking Trendy: Bank Nifty
Bank Nifty Trader
Sensex
FIN Nifty Trader
Key Indices
Day Trader’s Hit List
Visit us at www.sharekhan.com
For Private Circulation only
Sharekhan
Eagle Eye Equities
Punter’s Call
Bounce expected
December 21, 2023
Nifty daily: 21,255.05
The Nifty opened gap down by 116 points since then we
saw a pullback in the index. The Nifty closed in the green
by 104 points with a good bull candle which suggests
bounce will be continued. As expected, the Nifty
retested the pole and flag pattern levels given yesterday
at 21000-20800, the index made a low of 20976.80. The
daily momentum indicator has a positive crossover and
momentum indicator on hourly chart has given positive
crossover which indicates that the bounce would
continue. The low is important and if it is not broken out,
we can expect the index to touch the 21350-21450 level.
Other technical observations
60-minute
On the daily chart, the Nifty is trading above the 20day moving average (DMA) and the 40-DEMA of 20754
and 20386, respectively. The momentum indicator has a
positive crossover on the daily chart.
On the hourly chart, the Nifty is trading below the 20hour moving average (HMA) and the 40-HEMA of 21324
and 21276, respectively. The momentum indicator
has given positive crossover on the hourly charts. The
market breadth was positive with 1937 advances and
591 declines on the National Stock Exchange.
Market breadth
Todays Close
NSE
70,865.1
21,255.05
Advances
2,917
1,937
Decline
1,196
591
185
7,735.29
82
97,899.17
Unchanged
Volume (Rs. in Cr)
December 22, 2023
BSE
2
Sharekhan
Eagle Eye Equities
Looking Trendy: Nifty
Short Term Trend
Medium Term Trend
Index
Target
Trend
Reversal
Support /
Resistance
Index
Target
Trend
Reversal
Support /
Resistance
Nifty
22000
á
20600
20600 / 22000
Nifty
23500
á
19900
19900 / 23500
NOTE: Reversal on closing basis
NOTE: Reversal on closing basis
Looking Trendy: Sensex
Short Term Trend
Medium Term Trend
Index
Target
Trend
Reversal
Support /
Resistance
Index
Target
Trend
Reversal
Support /
Resistance
Sensex
72500
á
68800
68800 / 72500
Sensex
73500
á
66700
66700 / 73500
NOTE: Reversal on closing basis
á Up
NOTE: Reversal on closing basis
á
Icon guide
ßà Sideways
Down
Upswing matures
Downswing matures
Nifty Trader
Support
21100
20945
Resistance
21410
21565
20790
21720
20 DSMA
40 DEMA
20754
20386
Positional Weekly (Cash Only)
Date
Scrip Name
Action
20 Dec 23
CROMPTON
Buy
Stop Loss/
Reversal
Buy Price/
Sell Price
Stopped Out
305.30
Call
Closing
Price/CMP
293.00
Potential %
P/L at Exit/
Current
-4.03%
Potential %
P/L at Exit/
Current
-3.07%
Target 1
Target 2
317.00
325.00
Target 1
Target 2
90.00
96.00
NOTE: Kindly note that all stop losses in Chart Buster are on an intra-day basis.
Positional 15 Days (Cash Only)
Stop Loss/
Reversal
Buy Price/
Sell Price
Buy
71.90
79.75
Call
Closing
Price/CMP
77.30
BSOFT
Buy
675.00
710.05
723.15
1.84%
745.00
780.00
14 Dec 23
PETRONET
Buy
202.00
212.90
211.45
-0.68%
223.00
232.00
22 Nov 23
SAREGAMA
Buy
Stopped Out
376.40
354.00
-5.95%
395.90
429.90
Date
Scrip Name
18 Dec 23
HFCL
15 Dec 23
Action
NOTE: Kindly note that all stop losses in Chart Buster are on an intra-day basis.
1) The stop loss should be placed after 9.17am in order to avoid freak trade.
2) The same will be revised in the TradeTiger terminal every day for the pop-ups.
December 22, 2023
3
Sharekhan
Eagle Eye Equities
CTFT (Carry Today For Tomorrow) - Cash Only
Stop Loss/
Reversal
Buy Price/
Sell Price
Call Closing
Price/CMP
Buy
1933.00
1951.55
1957.70
Potential%
P/L at Exit/
Current
0.32%
TV18BRDCAST
Buy
49.40
51.35
51.35
TATACONSUM
Buy
Stopped Out
975.70
966.85
Date
Scrip Name
Action
21 Dec 23
GODREJPROP
21 Dec 23
20 Dec 23
Target 1
Target 2
1975.00
1999.00
0.00%
53.90
56.90
-0.91%
990.00
999.00
TPB: Trailing profit booked
1) The stop loss should be placed after 9.17am in order to avoid freak trade.
2) The same will be revised in the TradeTiger terminal every day for the pop-ups.
Looking Trendy: Bank Nifty
Short Term Trend
Medium Term Trend
Index
Target
Trend
Reversal
Support /
Resistance
Bank Nifty
49000
á
46000
46000 / 49000
NOTE: Reversal on closing basis
á Up
Target
Trend
Reversal
Support /
Resistance
Bank Nifty
50000
á
45000
45000 / 50000
NOTE: Reversal on closing basis
á
Icon guide
ßà Sideways
Down
Sensex
Downswing matures
Upswing matures
SENSEX
Support
Resistance
70512
71218
70159
71571
69806
71924
20 DSMA
40 DEMA
69094
68001
December 22, 2023
Index
4
Sharekhan
Eagle Eye Equities
Bank Nifty Trader
Bank Nifty
Support
Resistance
47540
48140
47240
48440
46940
48740
20 DSMA
40 DEMA
46393
45691
FIN Nifty Trader
FIN Nifty
Support
Resistance
21222
21430
21118
21534
21014
21638
20 DSMA
40 DEMA
20817
20468
Key Indices
Index
Target
Trend
Reversal
Support / Resistance
Nifty Auto
16500
â
18200
16500 / 18200
Nifty Fin Services
22000
á
20800
20800 / 22000
Nifty FMCG
55000
á
53700
53700 / 55000
Nifty Infra
7500
á
6850
6850 / 7500
Nifty IT
36700
á
33400
33400 / 36700
Nifty Metal
8000
á
7300
7300 / 8000
Nifty Pharma
17000
á
15800
15800 / 17000
Nifty Mid Cap 100
46000
á
42800
42800/46000
Nifty Small Cap 100
15100
á
13900
13900/15100
December 22, 2023
5
Sharekhan
Eagle Eye Equities
Day Trader’s Hit List
For December 22, 2023
Support Levels
Resistance Levels
S2
S1
Close
(Rs.)
Nifty
21100.0
21200.0
21255.05
21300.0
21400.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2
Bank Nifty
47600.0
47800.0
47840.15
47900.0
48100.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2
Axis Bank
1084.0
1090.0
1095.40
1105.0
1120.0 Buy at cmp target R1 and R2 SL S2
Bajaj Finance
7200.0
7300.0
7367.15
7388.0
7450.0 Sell at cmp target S1 and S2 SL R2
HDFC Bank
1670.0
1680.0
1686.70
1705.0
1725.0 Buy at cmp target R1 and R2 SL S2
Hindustan Unilever
2528.0
2550.0
2553.20
2575.0
2610.0 Buy at cmp target R1 and R2 SL S2
INFOSYS
1505.0
1530.0
1536.00
1541.0
1565.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2
ICICI Bank
994.0
1000.0
1004.40
1015.0
1030.0 Buy at cmp target R1 and R2 SL S2
ITC
447.0
450.0
451.45
456.0
461.0 Buy at cmp target R1 and R2 SL S2
Kotak Bank
1835.0
1844.0
1852.70
1870.0
1895.0 Buy at cmp target R1 and R2 SL S2
LT
3390.0
3410.0
3424.15
3460.0
3495.0 Buy at cmp target R1 and R2 SL S2
Maruti
9810.0
9990.0
10012.85
10050.0
Reliance Industries
2538.0
2558.0
2562.55
2585.0
2620.0 Buy at cmp target R1 and R2 SL S2
637.0
642.0
643.75
650.0
658.0 Buy at cmp target R1 and R2 SL S2
1220.0
1229.0
1233.50
1245.0
1260.0 Buy at cmp target R1 and R2 SL S2
129.0
130.0
131.00
132.5
135.0 Buy at cmp target R1 and R2 SL S2
TCS
3710.0
3780.0
3787.50
3800.0
3865.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2
Titan
3540.0
3575.0
3580.00
3615.0
3660.0 Buy at cmp target R1 and R2 SL S2
Zeel
257.0
261.0
262.20
263.0
Scrip Name
SBI
SunPharma
Tata Steel
December 22, 2023
R1
R2
Action
10200.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2
268.0 Buy Above R1 for a target of R2 or Sell Below S1 for a target of S2
6
DISCLAIMER
This information/document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is
addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission,
or any other use is strictly prohibited. This information/ document is subject to changes without prior notice.
Recommendation in reports based on technical and derivatives analysis is based on studying charts of a stock’s price movement, trading volume,
outstanding positions, as opposed to focusing on a company’s fundamentals and as such, may not match with a report on a company’s fundamentals.
However, this would only apply for information/document focused on technical and derivatives research and shall not apply to reports/documents/
information focused on fundamental research.
This information/document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official
confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report
at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this information/report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not
independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour
to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees
(“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other
reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must
not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily
a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information.
Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in
the securities of companies referred to in this document (including the merits and risks involved) and should consult its own advisors to determine
the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake
to advise you as to any change of our views. Affiliates of Sharekhan may have issued other recommendations/ reports that are inconsistent with and
reach different conclusions from the information presented in this recommendations/report.
This information/recommendation/report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident
of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law,
regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities
described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document
may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst might have dealt or traded directly or indirectly in securities of the company and that all the views expressed in
this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily
reflect those of SHAREKHAN. The analyst and SHAREKHAN further certifies that either he or his relatives or Sharekhan associates might have
direct or indirect financial interest or might have actual or beneficial ownership of 1% or more in the securities of the company at the end of the
month immediately preceding the date of publication of the research report. The analyst and SHAREKHAN encourages independence in research
report/ material preparation and strives to minimize conflict in preparation of research report. The analyst and SHAREKHAN does not have any
material conflict of interest or has not served as officer, director or employee or engaged in market making activity of the company. The analyst and
SHAREKHAN has not been a part of the team which has managed or co-managed the public offerings of the company, and no part of the analyst’s
compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document. Sharekhan Ltd or its
associates or analysts have not received any compensation for investment banking, merchant banking, brokerage services or any compensation or
other benefits from the subject company or from third party in the past twelve months in connection with the research report.
Either SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act
as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or
related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time
to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in
no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability
for any damages of any kind.
Forward-looking statements (if any) are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in
respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment. These statements are not a guarantee
of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown
risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of
future performance or result expressed or implied by such forward-looking statements. Sharekhan/its affiliates undertakes no obligation to update
forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities
laws. The reader/investors are cautioned not to place undue reliance on forward-looking statements and use their independent judgement before
taking any investment decision.
Investment in securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are for
illustration only and are not recommendatory. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the
intermediary or provide any assurance of returns to investors.
Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and the T&C on www.sharekhan.com
Registration and Contact Details: Name of Research Analyst - Sharekhan Limited, Research Analyst Regn No.: INH000006183. CIN): U99999MH1995PLC087498. Registered Office: The Ruby, 18th Floor, 29 Senapati Bapat Marg, Dadar (West), Mumbai – 400 028, Maharashtra, INDIA.
Tel: 022-6115000.
Correspondence/Administrative Office: Gigaplex IT Park, Unit No 1001, 10th Floor, Building No.9, TTC Industrial Area, Digha, Airoli-West,
Navi Mumbai – 400 708. Tel: 022 61169000 / 61150000, Fax No. 61169699.
Other registrations of Sharekhan Ltd.: SEBI Regn. Nos.: BSE / NSE / MSEI (CASH / F&O / CD) / MCX - Commodity: INZ000171337; DP: NSDL/CDSL-INDP-365-2018; PMS: INP000005786; Mutual Fund: ARN 20669.
Compliance Officer: Ms. Binkle Oza; Tel: 022-62263303; email id: complianceofficer@sharekhan.com
For any complaints/grievance, email us at igc@sharekhan.com or you may even call Customer Service desk on - 022- 41523200 / 022-69920600